Update cookies preferences

Ozempic gets green light for diabetes in India, Mystery illness kills 14 kids in Nagpur, Chhindwara Ausgewählte

380 Ansichten

0   0


In this segment of 5 Live, the focus is on the Indian drug regulator CDSCO's approval of the blockbuster drug Ozempic. It is cleared for treating type 2 diabetes and reducing risks of serious heart and kidney problems, but explicitly not for weight loss.


Mehr anzeigen
Kommentare

0 Kommentare

    Privacy Settings